- changes_MOO_v43_100115
- MOO_cover-1015
- MOO_spine-1015
- MOO-TOC-1015a
- MOO-Version-List-1015d
- Section_01-study_purpose-0414
- Section_02-organizational_structure-0415
- Section_03-Pub_Policy-1015
- Section_04-study_design-1015a
- Section_05-overview_of_baseline_visit_orig-recruits-1001
- Section_06-overview_of_baseline_visit_new_recruit-0415
- Section_07-follow-up_visits-1015a
- Section_08-guidelines_research_interview-0403
- Section_09-medical_exam-0415a
- Section_10a-laboratory_specimen_collection-0410
- Section_10-laboratory_specimen_collection-1015
- Section_10-sched.lab.eval-1015_allvisits
- Section_11_data management-0414
- Section_12-outcomes_ascertainment-1015
- Section_13-oral_protocol-1005
- Section_14-NIDA_HCU-1001
- Section_15-NIDA_I-V-1001
- Section_16-HHV-8_protocol-0403
- Section_17-interim_events_protocol-1004
- Section_18-pregnancy_protocol-1005
- Section_19-ACSR_protocol-1013
- Section_20-registry_matches-1015a
- Section_21-VRS-1003
- Section_22_anal_protocol_0403
- Section_23-MetTox_protocol-0403
- Section_24-hair_protocol-1015a
- Section_25-metabolic_prospective-0409a
- Section_26-PK-0412
- Section_27-sex_steroid-0806
- Section_28-pap_reread-0404
- Section_29_pbmc_iqa-0414
- Section_30-cvd-0414
- Section_31-repository-labeling-1015
- Section_33-phys_function-0405a
- Section_34-liver_ascertainment-1010
- Section_35-Vaccination-Card-Protocol-1106
- Section_36-MALT-1009
- Section_37-MSK_substudy-0414
- Section_38-ABI-1013a
- Section_39-CCSS-0415
- Section_40-Geocoding-1114
- Section_41-fibroscan_protocol-1015a
- Section_42-frailty-102215
WIHS ON TWITTER
FOLLOW USPrev>> Next>>
&nbps;